Stempeutics Research, a privately held Bangalore based Stem Cell company inaugurated its second Stem Cell research & therapeutics facility at the Manipal University campus.
Stempeutics manufacturing facility at Manipal is cGMP (current Good Manufacturing Practice) compliant. The facility is close to 5000 sq ft big with the state-of-art laboratory equipments and two class 10K clean rooms. It has been designed to meet the future plan of accreditation requirements of the USA Foundation for the Accreditation of cellular therapy (FACT) and the manufacturing process will adhere to cGTP (current Good Tissue Practice).
Supported by University, the state-of-the-art facility located at Shirdi Sai Baba Cancer Hospital is conceived to further leverage the research and clinical experience gained and also to address the needs of patients with limited treatment options for the conditions like Dilated Cardio Myopathy, End Stage Lever Disease and Osteoarthritis.
Dr Satish Totey, Chief Scientific Officer, Stempeutics Research said that the mission is to ethically and scientifically explore the full potential of stem cells to transform medicine and offer new hope to millions of people.
Research will be conducted on effective cell number, route of transplantation etc. Further research will be carried out to develop lineage specific cells or precursor cells for more effective therapy. He said that Stempeutics will use the animal house at the University for doing Pre Clinical studies.